Fate Therapeutics (FATE) names Matthew Abernethy to Board
Go back to Fate Therapeutics (FATE) names Matthew Abernethy to Board| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 3.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.02 | 52 Week High | $4.76 | |||
| Open | $3.02 | 52 Week Low | $1.46 | |||
| Day High | $3.02 | P/E | N/A | |||
| Day Low | $3.02 | EPS | $-1.91 | |||
| Volume | 2,752 | |||||
| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 177.49 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $177.49 | 52 Week High | $58.46 | |||
| Open | $177.49 | 52 Week Low | $31.25 | |||
| Day High | $177.49 | P/E | N/A | |||
| Day Low | $177.49 | EPS | $-0.69 | |||
| Volume | 70 | |||||
